In situ hybridization experiments were performed with brain sections from normal, control and haloperidol-treated rats to identify and map the cells expressing the D2 dopamine receptor gene. D2 receptor mRNA was detected with radioactive or biotinylated oligonucleotide probes. D2 receptor mRNA was present in glandular cells of the pituitary intermediate lobe and in neurons of the substantia nigra, ventral tegmental area, and forebrain, especially in caudate putamen, nucleus accumbens, olfactory tubercle, and piriform cortex. Hybridization with D2 and preproenkephalin A probes in adjacent sections, as well as combined hybridization with the two probes in the same sections, demonstrated that all detectable enkephalin neurons in the striatum contained the D2 receptor mRNA. Large neurons in caudate putamen, which were unlabeled with the preproenkephalin A probe and which may have been cholinergic, also expressed the D2 receptor gene. Haloperidol treatment (14 or 21 days) provoked an increase in mRNA content for D2 receptor and preproenkephalin A in the striatum. This suggests that the increase in D2 receptor number observed after haloperidol treatment is due to increased activity of the D2 gene. These results indicate that in the striatum, the enkephalin neurons are direct targets for dopamine liberated from mesostriatal neurons.
Biochemical and pharmacological investigations have demonstrated the existence of two dopamine receptor subtypes, D1 and D2, which differentiate the signal transduction mediated by dopamine as either an activation or an inhibition of adenylate cyclase (1) (2) (3) (4) . Rat D2 receptor cDNA has been cloned and sequenced, and it appears that the D2 receptor belongs to a family of receptors that are coupled to guanine nucleotide-binding proteins (5) . Its mRNA is abundantly represented in rat brain, especially in the mesencephalon and the basal ganglia (5) . These areas contain, respectively, the cell bodies and terminals of the dopaminergic mesostriatal system (6) . Striatal neuron activities are under the influence of the dopamine neurons of the substantia nigra and ventral tegmental area (7, 8) . Binding experiments with radiolabeled ligands have demonstrated the presence of striatal dopamine receptors (9) (10) (11) (12) (13) (14) (15) . Drugs that interact with dopamine at receptor sites significantly affect neuronal activities, including neuropeptide gene expression (16) (17) (18) (19) , in the striatum.
While the existence of dopamine receptors on striatal neurons and on dopamine terminals in the striatum is commonly accepted (9) (10) (11) (12) (13) (14) (15) , there is no anatomical information about the characteristics of the cells expressing the dopamine receptor gene in the striatum. To better understand how D2 receptor gene expression contributes to nigrostriatal interactions, we have used in situ hybridization to study the characteristics of cells containing D2 receptor mRNA in adult rat forebrain, under normal conditions and after blockade of dopamine transmission with a dopamine receptor antagonist, haloperidol. We report here that most cells containing D2 receptor mRNA in the striatum are enkephalin-producing neurons and that haloperidol treatment increases D2 receptor mRNA in the striatal enkephalin neurons. (20) . In brief, the rats were anesthetized with chloral hydrate and perfused through the heart with 1% formaldehyde. The brain was dissected out, immersed for 1 hr in the same fixative and then in sucrose/phosphate buffer for 16 hr, frozen over liquid nitrogen, and cut into 8-,um serial frontal sections that were collected on gelatin-coated slides and stored at -80°C until use.
METHODS
Probe Preparation and Labeling. The D2 receptor probes were prepared by using three 45-base synthetic oligodeoxynucleotides obtained by the phosphoramidite procedure. These oligonucleotides (5'-CCCATTGAAGGGCCGGCTC-CAGTTCTGCCTCTCCAGATCGTCATC-3'; 5'-GGCAAT-CATGACAGTAACTCGGCGCTTGGAGCTGTAGCGT-GTGTT-3'; 5'-GGAGGAGTAGACCACAAAGGCAGGGT-TGGCAATGATACACTCATT-3') were selected on the basis of the cloned cDNA sequence (5) and chosen in regions of the D2 receptor cDNA that had no homology with the other Abbreviation: PPA, preproenkephalin A.
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cDNAs of the same family. They had no significant homology with other sequences, including rat enkephalin, proopiocortin, somatostatin, and substance P cDNAs. The radioactive probe was prepared by using [a-[P5Sthio]dATP (New England Nuclear) and terminal deoxynucleotidyltransferase to add 35S-labeled tails to the three oligonucleotides (21) . Biotinylated probes were prepared by addition of a tail of biotin-21-dU, using biotin-21-dUTP (Genofit, Geneva) (21), or by fixation of a tail of 10 biotin molecules to the 5' end of the oligonucleotides during synthesis as described (32) .
The probe recognizing the enkephalin precursor [preproenkephalin A (PPA)] mRNA was a 0.4-kilobase doublestranded cDNA fragment of the rat PPA cDNA cloned by Proc. Natl. Acad. Sci. USA 87 (1990)
Yoshikawa et al., and used in previous studies (22) . It was used after labeling by nick-translation with incorporation of [aT-5S]thio]dATP or of biotin-21-dUTP as described (20, 21) .
In Situ Hybridization Protocol and Signal Detection. Hybridization with D2 and PPA radioactive probes. Hybridization with 35S-labeled probe was performed as described (20, 21) ; D2 receptor probe (1 ng) or PPA probe (2 ng) was deposited on slides and hybridized overnight at 40TC. Sections were left 3-5 days in contact with x-ray film (Kodak X-Omat) and then coated with Ilford K-5 emulsion, exposed for 2-4 weeks, developed, and stained with toluidine blue. situ hybridization reaction for D2 receptor mRNA included the use of unrelated probes (somatostatin, vasopressin), the use of hybridization medium without radioactive probes, and the addition of related or unrelated unlabeled oligonucleotides to the hybridization medium as described (21) . Hybridization with biotinylated D2 probe. Biotinylated oligonucleotide probe (2 ng) was deposited on slides and incubated overnight at 40'C. After rinsing, the biotin was detected with streptavidin-alkaline phosphatase and nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate as described (21) .
Combined hybridization with radioactive D2 probe and biotinylated PPA probe. 35S-labeled D2 probe and biotinylated PPA cDNA (1 ng and 4 ng per 20 ILI, respectively) were mixed in hybridization buffer, deposited on slides, and incubated overnight at 40°C. After rinsing, the sections were incubated with streptavidin-alkaline phosphatase and its substrate (21) . Sections were then rinsed in distilled water, coated with gelatin, and allowed to dry. They were secondarily coated with Ilford K-5 emulsion, exposed 3-4 weeks, and developed.
RESULTS
Characteristics of the Cells Labeled with the D2 Receptor Probes. Several areas were labeled on x-ray film with the radioactive D2 probe: the caudate putamen and accumbens nucleus were intensely and homogenously stained, as well as the olfactory tubercle and piriform cortex (Fig. 1) . A faint and inconsistent reaction was observed in the superficial and deep layers of the frontal and parietal cortex. The substantia nigra, the ventral tegmental area, and the intermediate lobe of the pituitary were intensely labeled (Fig. 1) . Microautoradiography showed that the silver grains were accumulated over brain cells having a neuronal aspect. In the caudate putamen and nucleus accumbens, these cells appeared mostly as clusters of small neurons (10-15 ,um in diameter; 98% of labeled cells; Fig. 2 B, D, and F) . A few large neurons with prominent cytoplasm (30-35 pum in diameter; 2% of labeled cells) were also labeled in the caudate putamen nucleus (Fig. 2E) . The olfactory tubercle and piriform cortex showed two or three layers of densely packed reactive neurons (Fig. 2 B and C) . The biotinylated probes provided the same pattern of reaction (Fig. 2F) . In the substantia nigra, most neurons of the pars compacta were intensely reactive. A concentration-dependent disappearance of the labeling was noted when various amounts of unlabeled D2 receptor oligonucleotide probe were added to the hybridization buffer (the signal disappeared when 20-or 50-fold excess unlabeled probe was added). No modification of the autoradiographic reaction intensity or aspect was observed when unrelated oligonucleotides were used as competitors. Neurons demonstrating the PPA mRNA displayed topography and aspect very similar to the ones reactive with the D2 probe in the forebrain ( Fig. 2 A and B) , with two noticeable differences: no reaction was found in the septum with the D2 receptor probe, and no large neurons were labeled in the striatum with the PPA probe.
Detection of D2 and PPA mRNAs in Haloperidol-Treated
Rat. The topography and aspect of labeling with the D2 probe were the same in normal, control, and haloperidol-treated rats. Densitometric and microscopic analyses demonstrated a significant increase in PPA and D2 receptor mRNA content over the caudate putamen area after haloperidol treatment (Table 1 and Fig. 2 D and E ). Increases at 14 or 21 days were not significantly different.
Comparative Analysis of D2 and PPA mRNA Localization. Simultaneous detection of D2 receptor mRNA and PPA mRNA in the same sections demonstrated that all detectable PPA neurons of the caudate putamen, nucleus accumbens, piriform cortex, and olfactory tubercle also contained D2 mRNA (Fig. 3 ) in normal and haloperidol-treated rats. All doubly reactive cells were small neurons (10-15 pum in diameter); the staining intensity for D2 mRNA varied greatly from one neuron to another. A few areas containing the D2 mRNA were not reactive with the PPA probe. They could correspond to the large neurons observed with toluidine blue (Fig. 2D) . Control experiments demonstrated the absence of silver grains over the PPA neurons in the striatum when the radioactive D2 probe was replaced by a radioactive rat vasopressin probe.
DISCUSSION
The cloning of a dopamine receptor cDNA (5) has opened the way for anatomical investigations and pharmacological studies of dopamine receptor gene expression at the biochemical and cellular levels. Our use of oligonucleotide probes to detect D2 receptor mRNA in neurons of the substantia nigra and forebrain and in glandular cells of the pituitary intermediate lobe corroborates numerous previous studies that have used receptor binding assays to detect D2 receptors in these areas (9-14, 24, 25) . Our results also correlate with Northern blot detection of the D2 receptor mRNA with a cDNA probe (5) . The specificity of our results is confirmed by the characteristic pattern of localization of the reaction as well as by our control experiments, including those in which a selective, concentration-dependent decrease in the signal was observed after addition of unlabeled D2 probe to the hybridization medium. The presence of D2 mRNA in neurons of the substantia nigra and ventral tegmental area confirms that mesencephalic dopamine neurons are the source ofdopamine autoreceptors in these areas (24) . The presence of D2 mRNA in neurons of the striatum demonstrates that the D2 receptor gene is expressed there by cells whose activity is regulated by the mesencephalic dopamine neurons. This result demonstrates the production of postsynaptic D2 receptors in striatal neurons (13) . Nevertheless, since mRNA is present in cell bodies and possibly in dendrites but not in axons or terminals, presynaptic D2 receptors located on afferent terminals (including the dopamine ones) are most probably produced in the corresponding cell bodies outside the striatum, as suggested by others (13) .
Two striatal cell types were shown to express the D2 receptor gene. The most prominent one corresponds to the neurons containing detectable PPA mRNA in the caudate putamen, nucleus accumbens, olfactory tubercle, and piriform cortex. This result suggests that the dopamine released in the striatum binds directly to D2 receptors located on PPA neurons, a hypothesis that correlates with (i) the presence of dopamine nerve endings in contact with enkephalin neurons in the rat caudate putamen (26) and (ii) the effects of dopamine antagonists and substantia nigra lesions on PPA neuron activity (16-19, 27, 28 (29) . Dopamine inhibits acetylcholine release in the striatum (30) , and binding experiments strongly suggest that acetylcholine neurons have dopamine receptors (14) . Several other neurotransmitters and neuropeptides are produced in the striatum. Further evaluation using specific markers is now needed to know unequivocally if cholinergic neurons or other neuronal populations could also express the D2 gene. Preliminary investigations have shown that striatal somatostatin neurons are unlabeled with the D2 probe (unpublished results 
